These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 37237244)

  • 21. HLF regulates ferroptosis, development and chemoresistance of triple-negative breast cancer by activating tumor cell-macrophage crosstalk.
    Li H; Yang P; Wang J; Zhang J; Ma Q; Jiang Y; Wu Y; Han T; Xiang D
    J Hematol Oncol; 2022 Jan; 15(1):2. PubMed ID: 34991659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. COL5A1 promotes triple-negative breast cancer progression by activating tumor cell-macrophage crosstalk.
    Chen X; Ma C; Li Y; Liang Y; Chen T; Han D; Luo D; Zhang N; Zhao W; Wang L; Yang Q
    Oncogene; 2024 Jun; 43(23):1742-1756. PubMed ID: 38609499
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FOXM1 derived from Triple negative breast cancer exosomes promotes cancer progression by activating IDO1 transcription in macrophages to suppress ferroptosis and induce M2 polarization of Tumor-associated macrophages.
    Wang T; Zhang Y; Liu H; Wu J
    Genes Genet Syst; 2024 Oct; ():. PubMed ID: 39428479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RAB5A in triple-negative breast cancer: a critical role in macrophage reshaping in an exosomal miR-21-dependent manner.
    Qiao L; Dong C; Jia W; Sun G
    Endocr Relat Cancer; 2024 May; 31(5):. PubMed ID: 38470169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of tumor-derived extracellular vesicle-shuttled lncRNA MALAT1 on proliferation, invasion and metastasis of triple-negative breast cancer by regulating macrophage M2 polarization via the POSTN/Hippo/YAP axis.
    Wang X; Jian Q; Zhang Z; Gu J; Wang X; Wang Y
    Transl Oncol; 2024 Nov; 49():102076. PubMed ID: 39222611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting prooxidant MnSOD effect inhibits triple-negative breast cancer (TNBC) progression and M2 macrophage functions under the oncogenic stress.
    Al Haq AT; Tseng HY; Chen LM; Wang CC; Hsu HL
    Cell Death Dis; 2022 Jan; 13(1):49. PubMed ID: 35017469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The GRP94 Inhibitor PU-WS13 Decreases M2-like Macrophages in Murine TNBC Tumors: A Pharmaco-Imaging Study with
    Bouchard A; Sikner H; Baverel V; Garnier AR; Monterrat M; Moreau M; Limagne E; Garrido C; Kohli E; Collin B; Bellaye PS
    Cells; 2021 Dec; 10(12):. PubMed ID: 34943901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-200c/PAI-2 promotes the progression of triple negative breast cancer via M1/M2 polarization induction of macrophage.
    Meng Z; Zhang R; Wang Y; Zhu G; Jin T; Li C; Zhang S
    Int Immunopharmacol; 2020 Apr; 81():106028. PubMed ID: 31801690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting epidermal growth factor receptor in paclitaxel-resistant human breast and lung cancer cells with upregulated glucose-6-phosphate dehydrogenase.
    Min HY; Lee HJ; Suh YA; Pei H; Kwon H; Jang HJ; Yun HJ; Moon HG; Lee HY
    Br J Cancer; 2022 Sep; 127(4):661-674. PubMed ID: 35597872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LncRNA-HOXC-AS2 regulates tumor-associated macrophage polarization through the STAT1/SOCS1 and STAT1/CIITA pathways to promote the progression of non-small cell lung cancer.
    Yin C; Li J; Li S; Yang X; Lu Y; Wang C; Liu B
    Cell Signal; 2024 Mar; 115():111031. PubMed ID: 38168631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR-149 Suppresses Breast Cancer Metastasis by Blocking Paracrine Interactions with Macrophages.
    Sánchez-González I; Bobien A; Molnar C; Schmid S; Strotbek M; Boerries M; Busch H; Olayioye MA
    Cancer Res; 2020 Mar; 80(6):1330-1341. PubMed ID: 31911555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of macrophage--cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer.
    Hollmén M; Roudnicky F; Karaman S; Detmar M
    Sci Rep; 2015 Mar; 5():9188. PubMed ID: 25776849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HUNK as a key regulator of tumor-associated macrophages in triple negative breast cancer.
    Ramos Solis N; Cannon A; Dilday T; Abt M; Oblak AL; Soloff AC; Kaplan MH; Yeh ES
    Oncoimmunology; 2024; 13(1):2364382. PubMed ID: 38846083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor-derived exosomal miR-148b-3p mediates M2 macrophage polarization via TSC2/mTORC1 to promote breast cancer migration and invasion.
    Hao C; Sheng Z; Wang W; Feng R; Zheng Y; Xiao Q; Zhang B
    Thorac Cancer; 2023 Jun; 14(16):1477-1491. PubMed ID: 37144254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Crosstalk between hepatic tumor cells and macrophages via Wnt/β-catenin signaling promotes M2-like macrophage polarization and reinforces tumor malignant behaviors.
    Yang Y; Ye YC; Chen Y; Zhao JL; Gao CC; Han H; Liu WC; Qin HY
    Cell Death Dis; 2018 Jul; 9(8):793. PubMed ID: 30022048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ligustilide counteracts carcinogenesis and hepatocellular carcinoma cell-evoked macrophage M2 polarization by regulating yes-associated protein-mediated interleukin-6 secretion.
    Yang J; Xing Z
    Exp Biol Med (Maywood); 2021 Sep; 246(17):1928-1937. PubMed ID: 34053234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Streptococcus virulence protein PepO triggers anti-tumor immune responses by reprograming tumor-associated macrophages in a mouse triple negative breast cancer model.
    Liu B; Huang J; Xiao J; Xu W; Zhang H; Yuan Y; Yin Y; Zhang X
    Cell Biosci; 2023 Nov; 13(1):198. PubMed ID: 37925462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extracellular vesicle-packaged miR-181c-5p from epithelial ovarian cancer cells promotes M2 polarization of tumor-associated macrophages via the KAT2B/HOXA10 axis.
    Yang S; Zhao H; Xiao W; Shao L; Zhao C; Sun P
    J Gene Med; 2022 Oct; 24(10):e3446. PubMed ID: 36027869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. S100A9 promotes tumor-associated macrophage for M2 macrophage polarization to drive human liver cancer progression: An in vitro study.
    Yang LF; Zhang ZB; Wang L
    Kaohsiung J Med Sci; 2023 Apr; 39(4):345-353. PubMed ID: 36807724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Piceatannol Prevents Colon Cancer Progression via Dual-Targeting to M2-Polarized Tumor-Associated Macrophages and the TGF-β1 Positive Feedback Signaling Pathway.
    Chiou YS; Lan YM; Lee PS; Lin Q; Nagabhushanam K; Ho CT; Pan MH
    Mol Nutr Food Res; 2022 Aug; 66(15):e2200248. PubMed ID: 35616191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.